The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying product supplement, underlier supplement, prospectus supplement and prospectus are not an offer to sell these securities and we are not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
... (continue reading...)
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-277211
October 5, 2026
PRICING SUPPLEMENT
(To Prospectus dated February 21, 2024,
Prospectus Supplement dated February 21, 2024 and
Equity Index Underlying Supplement dated February 21, 2024)
HSBC USA Inc.
$75,000
Buffered Uncapped Market... (continue reading...)
BofA Finance LLC $737,000
Buffered Auto-Callable Notes
Fully and Unconditionally Guaranteed by Bank of America Corporation
Pricing Supplement
(To Prospectus dated December 8,... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K Banco BBVA Argentina For: Dec 31
-
Form 4 Clean Energy Fuels Corp. For: Oct 06 Filed by: Armstrong Jason J.
-
Form 424B3 Pulmatrix, Inc.
-
Form 4 Intapp, Inc. For: Oct 05 Filed by: HALL JOHN T
-
Form 425 CENTERSPACE Filed by: INDEPENDENCE REALTY TRUST, INC.
-
Form SCHEDULE 13G CDT Equity Inc. Filed by: Primary Development Fund (Cayman) SPC - E3 Fund SP
-
Form 6-K SOS Ltd For: Jun 30
-
Form 4 Humacyte, Inc. For: Oct 06 Filed by: COWARD D SCOTT
-
Form 424B3 INDEPENDENCE REALTY TRUS
-
Form 424B5 Matternet, Inc.
-
Form F-6EF CREATIVE TECHNOLOGY LTD Filed by: Citibank,N.A./ADR
-
Form 4 PROGRESS SOFTWARE CORP For: Oct 05 Filed by: WANG YUFAN STEPHANIE
-
Form DEF 14A SLR Investment Corp. For: Nov 18
-
Form 8-K MICROVISION, INC. For: Oct 07
-
Form S-1/A Retension Pharmaceutical
-
Form 8-K Riley Exploration Permia For: Oct 05
-
Form 8-K Medicus Pharma Ltd. For: Oct 07
-
Form SCHEDULE 13D/A Mistras Group, Inc. Filed by: Foglia Stephanie Athena
-
Form SCHEDULE 13G/A CDT Equity Inc. Filed by: Taylor Mark Andrew
-
Form 4 Pebblebrook Hotel Trust For: Oct 01 Filed by: Bayless William C Jr
-
Form 4 Canadian Solar Inc. For: Oct 06 Filed by: Ruda Harry E
-
Form 8-K Advasa Holdings, Inc. For: Oct 07
-
Form 8-K/A Ocean Power Technologies For: Sep 30
-
Form 3 Clean Energy Fuels Corp. For: Oct 06 Filed by: Armstrong Jason J.
-
Form DEFA14A Pulmatrix, Inc.
-
Form 3 A10 Networks, Inc. For: Oct 05 Filed by: Henry Mary C
-
Form SCHEDULE 13G/A CDT Equity Inc. Filed by: Wigglesworth Craig Stuart
-
Form 8-K RESOURCES CONNECTION, For: Oct 07
-
Form 253G2 OBSIDIAN PRIME INC
-
Form 6-K Diginex Ltd For: Oct 07
-
Form 6-K Kanzhun Ltd For: Oct 07
-
Form 6-K Genenta Science S.p.A. For: Oct 07
-
Form 8-K Unusual Machines, Inc. For: Oct 05
-
Form SCHEDULE 13D/A Silvia, Inc. Filed by: Pompliano Anthony John III
-
Form 8-K Matternet, Inc. For: Oct 01
-
Form RW BIOTRICITY INC.
-
Form SCHEDULE 13D/A MID PENN BANCORP INC Filed by: NORCROSS PHILIP A
-
Form 6-K TDH Holdings, Inc. For: Oct 07
-
Form 4 Twist Bioscience Corp For: Oct 05 Filed by: Leproust Emily M.
-
Form 144 IDT CORP Filed by: MASON JOYCE J
-
Form 3 ACCURAY INC For: Oct 05 Filed by: MEIER RICHARD A
-
Form 4 Humacyte, Inc. For: Oct 06 Filed by: Kuznik Paul Brian
-
Form 4 APPLIED OPTOELECTRONICS, For: Oct 05 Filed by: Yeh Shu-Hua (Joshua)
-
Form 13F-HR RHODES INVESTMENT ADVISO For: Sep 30
-
Form 4 Moderna, Inc. For: Oct 05 Filed by: Mock James M
-
Form 4 SOPHiA GENETICS SA For: Oct 05 Filed by: Valente Manuela
-
Form 4 SOPHiA GENETICS SA For: Oct 05 Filed by: Van Well Daan
-
Form 4 SOPHiA GENETICS SA For: Oct 05 Filed by: Verma Abhimanyu
-
Form 4 SOPHiA GENETICS SA For: Oct 05 Filed by: Puylaert Kevin
-
Form 4 SOPHiA GENETICS SA For: Oct 05 Filed by: Menu Philippe


